These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15473157)

  • 1. A stochastic model of vaccine trials for endemic infections using group randomization.
    Riggs TW; Koopman JS
    Epidemiol Infect; 2004 Oct; 132(5):927-38. PubMed ID: 15473157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maximizing statistical power in group-randomized vaccine trials.
    Riggs T; Koopman JS
    Epidemiol Infect; 2005 Dec; 133(6):993-1008. PubMed ID: 16274496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No evidence for Haemophilus influenzae serotype replacement in Europe after introduction of the Hib conjugate vaccine.
    Ladhani S; Ramsay ME; Chandra M; Slack MP;
    Lancet Infect Dis; 2008 May; 8(5):275-6. PubMed ID: 18471770
    [No Abstract]   [Full Text] [Related]  

  • 4. Modelling transmission, immunity and disease of Haemophilus influenzae type b in a structured population.
    Auranen K; Eichner M; Leino T; Takala AK; Mäkelä PH; Takala T
    Epidemiol Infect; 2004 Oct; 132(5):947-57. PubMed ID: 15473159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finnish efficacy trials with Haemophilus influenzae type b vaccines.
    Eskola J; Peltola H; Käyhty H; Takala AK; Mäkelä PH
    J Infect Dis; 1992 Jun; 165 Suppl 1():S137-8. PubMed ID: 1588148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugate vaccines for preventing Haemophilus influenzae type b infections.
    Swingler G; Fransman D; Hussey G
    Cochrane Database Syst Rev; 2003; (4):CD001729. PubMed ID: 14583937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary: results of efficacy trials in Alaska and Finland of Haemophilus influenzae type b conjugate vaccine.
    Ward J
    Pediatrics; 1990 Apr; 85(4 Pt 2):667. PubMed ID: 2179858
    [No Abstract]   [Full Text] [Related]  

  • 8. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.
    Santosham M; Wolff M; Reid R; Hohenboken M; Bateman M; Goepp J; Cortese M; Sack D; Hill J; Newcomer W
    N Engl J Med; 1991 Jun; 324(25):1767-72. PubMed ID: 1903846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatrics academy issues recommendations on use of Haemophilus influenzae type b conjugate vaccine.
    Clin Pharm; 1988 Sep; 7(9):634. PubMed ID: 3266482
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of vaccines and antibiotic prophylaxis in contacts and cases of Haemophilus influenzae type b (Hib) disease.
    Cartwright KA; Begg NT; Rudd PT
    Commun Dis Rep CDR Rev; 1994 Feb; 4(2):R16-7. PubMed ID: 7511459
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine.
    Leach AJ; Wigger C; Hare K; Hampton V; Beissbarth J; Andrews R; Chatfield M; Smith-Vaughan H; Morris PS
    BMC Pediatr; 2015 Oct; 15():162. PubMed ID: 26482232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United Kingdom.
    Tudor-Williams G; Frankland J; Isaacs D; Mayon-White RT; MacFarlane JA; Rees DG; Moxon ER
    Arch Dis Child; 1989 Apr; 64(4):520-4. PubMed ID: 2665657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
    Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
    Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing a vaccine to prevent otitis media caused by nontypeable Haemophilus influenzae.
    Khan MN; Ren D; Kaur R; Basha S; Zagursky R; Pichichero ME
    Expert Rev Vaccines; 2016 Jul; 15(7):863-78. PubMed ID: 26894630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of Haemophilus influenzae type b polysaccharide vaccine.
    Granoff DM; Osterholm MT
    Pediatrics; 1987 Oct; 80(4):590-2. PubMed ID: 3498928
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemophilus influenzae infections following licensure of the Hib vaccine.
    Alexander WJ; Shaw JF; Holmes JR
    N Engl J Med; 1987 Jul; 317(3):167-8. PubMed ID: 3496536
    [No Abstract]   [Full Text] [Related]  

  • 17. Update on non-typeable Haemophilus influenzae-mediated disease and vaccine development.
    Jalalvand F; Riesbeck K
    Expert Rev Vaccines; 2018 Jun; 17(6):503-512. PubMed ID: 29863956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
    Eskola J; Käyhty H; Takala AK; Peltola H; Rönnberg PR; Kela E; Pekkanen E; McVerry PH; Mäkelä PH
    N Engl J Med; 1990 Nov; 323(20):1381-7. PubMed ID: 2233904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update: Haemophilus influenzae b polysaccharide vaccine.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(9):144-5. PubMed ID: 3080673
    [No Abstract]   [Full Text] [Related]  

  • 20. [Haemophilus vaccines. Their importance in tropical pediatrics].
    Bégué P
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):912-6. PubMed ID: 1819437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.